SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 332 filers reported holding SEATTLE GENETICS INC in Q3 2018. The put-call ratio across all filers is 0.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $45,506,000 | +14.7% | 232,542 | -0.4% | 0.02% | 0.0% |
Q2 2020 | $39,676,000 | +55.8% | 233,490 | +5.8% | 0.02% | +33.3% |
Q1 2020 | $25,464,000 | -9.6% | 220,705 | -10.5% | 0.01% | +20.0% |
Q4 2019 | $28,171,000 | +35.5% | 246,551 | +1.3% | 0.01% | +25.0% |
Q3 2019 | $20,790,000 | +15.5% | 243,426 | -6.4% | 0.01% | +14.3% |
Q2 2019 | $17,998,000 | -7.4% | 260,040 | -2.0% | 0.01% | -12.5% |
Q1 2019 | $19,435,000 | +33.9% | 265,350 | +3.6% | 0.01% | +14.3% |
Q4 2018 | $14,514,000 | -25.8% | 256,150 | +0.9% | 0.01% | -12.5% |
Q3 2018 | $19,569,000 | +21.8% | 253,767 | +4.9% | 0.01% | +14.3% |
Q2 2018 | $16,068,000 | +34.4% | 242,023 | +5.9% | 0.01% | +40.0% |
Q1 2018 | $11,959,000 | +1.0% | 228,463 | +3.2% | 0.01% | 0.0% |
Q4 2017 | $11,842,000 | +8.1% | 221,319 | +10.0% | 0.01% | 0.0% |
Q3 2017 | $10,951,000 | +7.3% | 201,280 | +2.0% | 0.01% | 0.0% |
Q2 2017 | $10,210,000 | -17.8% | 197,348 | -0.2% | 0.01% | -28.6% |
Q1 2017 | $12,426,000 | +23.0% | 197,688 | +3.2% | 0.01% | +40.0% |
Q4 2016 | $10,106,000 | -8.8% | 191,500 | -6.7% | 0.01% | -16.7% |
Q3 2016 | $11,085,000 | +32.3% | 205,238 | -1.0% | 0.01% | +20.0% |
Q2 2016 | $8,376,000 | +11.8% | 207,282 | -2.9% | 0.01% | 0.0% |
Q1 2016 | $7,493,000 | -15.9% | 213,546 | +7.5% | 0.01% | -16.7% |
Q4 2015 | $8,914,000 | +0.7% | 198,646 | -13.4% | 0.01% | -14.3% |
Q3 2015 | $8,848,000 | -27.4% | 229,461 | -8.8% | 0.01% | -12.5% |
Q2 2015 | $12,181,000 | +44.6% | 251,679 | +5.6% | 0.01% | +33.3% |
Q1 2015 | $8,422,000 | +33.9% | 238,243 | +21.7% | 0.01% | +50.0% |
Q4 2014 | $6,291,000 | +10.1% | 195,807 | +27.5% | 0.00% | 0.0% |
Q3 2014 | $5,712,000 | +9.0% | 153,603 | +12.1% | 0.00% | 0.0% |
Q2 2014 | $5,242,000 | +0.7% | 137,052 | +19.9% | 0.00% | 0.0% |
Q1 2014 | $5,207,000 | +3.7% | 114,262 | -9.2% | 0.00% | 0.0% |
Q4 2013 | $5,022,000 | -32.3% | 125,906 | -25.6% | 0.00% | -33.3% |
Q3 2013 | $7,421,000 | +58.6% | 169,304 | +13.8% | 0.01% | +50.0% |
Q2 2013 | $4,678,000 | – | 148,724 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 51,046,060 | $2,892,270,000 | 23.68% |
Lagoda Investment Management, L.P. | 88,615 | $5,021,000 | 8.38% |
Matrix Capital Management Company, LP | 3,141,852 | $178,017,000 | 5.90% |
Opus Point Partners Management, LLC | 19,127 | $1,084,000 | 2.39% |
EMORY UNIVERSITY | 41,539 | $2,354,000 | 1.86% |
Capital International Sarl | 238,100 | $13,491,000 | 1.62% |
Rhenman & Partners Asset Management AB | 242,198 | $13,723,000 | 1.57% |
CAPITAL GUARDIAN TRUST CO | 1,341,050 | $75,984,000 | 1.21% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 42,500 | $1,890,000 | 1.17% |
JGP Global Gestao de Recursos Ltda. | 16,524 | $936,000 | 1.14% |